Filing Details

Accession Number:
0001144204-11-020926
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-08 13:06:17
Reporting Period:
2011-04-06
Filing Date:
2011-04-08
Accepted Time:
2011-04-08 13:06:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1321646 Kraton Performance Polymers Inc. KRA Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821) 200411521
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1243235 P L Manager Fund Master Jpmp C/O J.p. Morgan Partners, Llc
270 Park Avenue
New York NY 10017
No No Yes No
1281161 P L Investors Global Jpmp C/O J.p. Morgan Partners, Llc
270 Park Avenue
New York NY 10017
No No Yes No
1330534 Jpmp Capital Corp C/O J.p. Morgan Partners, Llc
270 Park Avenue
New York NY 10017
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-04-06 3,995,229 $36.05 7,226 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. See Exhibit 99.1
  2. This represents a disposition of the Issuer's securities by JPMP BHCA and the Global Funds (as defined within Exhibit 99.1) and is jointly filed by the other reporting persons as described in Exhibit 99.1
  3. Includes 7,226 shares of common stock of Kraton Performance Polymers, Inc., representing $50,000 of common stock of Kraton Performance Polymers, Inc. granted to each of Timothy J. Walsh and Kevin G. O'Brien in consideration of their service on the Board of Directors of the Issuer. The price of the stock is based upon the average of the high and low prices of the common stock of Kraton Performance Polymers, Inc. as reported on the New York Stock Exchange on January 28, 2010. Pursuant to contractual undertakings by Mr. Walsh and Mr. O'Brien, Mr. Walsh and Mr. O'Brien are each holding these shares for the benefit of JPMP BHCA.